CVX vs ISRG: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Intuitive Surgical, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Chevron Corporation · Energy
$205.52
+35.9% upside to fair value
Med Conviction
Grade B
High Quality
VS
Intuitive Surgical, Inc. · Healthcare
$399.52
+22.4% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
CVX has more upside to fair value
(+35.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
ISRG |
| Current Price |
$205.52 |
$399.52 |
| Fair Value Estimate |
$279.29 |
$488.97 |
| Upside to Fair Value |
+35.9%
|
+22.4%
|
| Market Cap |
$409.3B |
$141.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
7.8x
|
30.7x
|
| Price / Sales |
2.0x
|
12.8x
|
| Price / FCF |
15.0x
|
44.0x
|
| Revenue Growth YoY |
+51.4%
|
+18.5%
|
| Gross Margin |
31.0%
|
66.7%
|
| Operating Margin |
15.8%
|
31.3%
|
| Return on Equity |
11.0%
|
17.8%
|
| Dividend Yield |
3.43% |
0% |
| FCF Yield |
6.67%
|
2.28%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Chevron is a global integrated oil and gas major organized into Upstream and Downstream segments, spanning crude oil and natural gas exploration, LNG processing and transport, refining, petrochemicals, and lubricants, with 43,039 full-time employees and a market capitalization of $409.31 billion at a current price of $205.52. The business quality is high: it generates $13.71 of free cash flow per…
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with …
Accumulation Zones
| Metric |
CVX |
ISRG |
| Zone Low |
$209.47 |
$366.73 |
| Zone High |
$237.40 |
$415.62 |
| In Buy Zone? |
Yes
|
Yes
|